KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment-Reference-Cited by-同舟云学术

KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment

Published:2014-07-07 Issue:12 Volume:74 Page:1222-1230
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Dijkstra Siebren¹,Leyten Gisele H. J. M.¹,Jannink Sander A.²,de Jong Hans²,Mulders Peter F. A.¹,van Oort Inge M.¹,Schalken Jack A.¹²

Affiliation:

1. Department of Urology; Radboud University Medical Center; Nijmegen the Netherlands

2. Department of Research and Development; NovioGendix; Nijmegen the Netherlands

Funder

EFRO, ULTRASENSE MR

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.22839/fullpdf

Reference30 articles.

1. Characterising the castration-resistant prostate cancer population: A systematic review;Kirby;Int J Clin Pract,2011

2. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

3. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: A randomised open-label trial;de Bono;Lancet,2010

4. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

5. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Implementation of a Noninvasive, Multi-Analyte Droplet Digital PCR Test to Screen for Androgen Receptor Alterations;The Journal of Molecular Diagnostics;2024-06

2. A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer;Pathology - Research and Practice;2022-03

3. Liquid biopsy as a new tool for diagnosis, monitoring, and personalized medicine in urogenital cancers;Liquid Biopsy in Urogenital Cancers and its Clinical Utility;2022

4. Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC);International Journal of Molecular Sciences;2021-12-21

5. Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment;Molecular Oncology;2021-05-29